Skip to main content
. 2022 Apr 16;107(7):e2680–e2689. doi: 10.1210/clinem/dgac217

Figure 2.

Figure 2.

Sustained improvement in height SD score (SDS) for fliGHt subjects. Height SDS over 78 weeks in subjects who had been previously treated with daily somatropin before enrolling in the fliGHt trial (weekly lonapegsomatropin, light purple background) and then continuing in the enliGHten trial (weekly lonapegsomatropin, light orange background). *Based on n= 146 at fliGHt baseline.